Portfolio company
Arcellx
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This biotechnology company develops cell therapies to treat patients with cancer and autoimmune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Autolus Therapeutics
This company develops programmed T-cell therapies for patients with cancer and autoimmune diseases.
Century Therapeutics
This biotechnology company develops induced pluripotent stem cell-derived therapies to treat patients with cancer and autoimmune diseases.
Artiva Biotherapeutics
The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.
Cullinan Oncology
This company develops therapies for patients living with autoimmune diseases and cancer.
Clade Therapeutics
This biotechnology company develops stem cell-derived medicines to treat patients with cancer and autoimmune diseases.
Cabaletta Bio
This clinical-stage biotechnology company develops engineered T cell therapies for patients with various autoimmune diseases.
ArgenX
This company develops and commercialises antibody-based therapies to treat patients suffering from severe autoimmune diseases and cancer.
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
